- Report
- August 2025
- 195 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 194 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 188 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 197 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 182 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 199 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 190 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- December 2025
- 150 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- September 2025
- 150 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- May 2025
- 261 Pages
Global
From €5207EUR$5,950USD£4,527GBP
- Report
- May 2025
- 200 Pages
Global
From €2179EUR$2,490USD£1,894GBP
- Report
- October 2025
- 144 Pages
Global
From €3500EUR$3,999USD£3,042GBP
- Report
- September 2025
- 150 Pages
Global
From €3500EUR$3,999USD£3,042GBP
- Report
- May 2025
- 140 Pages
Global
From €3500EUR$3,999USD£3,042GBP
- Report
- April 2025
- 138 Pages
Global
From €3500EUR$3,999USD£3,042GBP
- Report
- December 2025
- 200 Pages
Global
From €2179EUR$2,490USD£1,894GBP
- Report
- June 2025
- 193 Pages
Global
From €3938EUR$4,500USD£3,423GBP
- Report
- January 2026
- 183 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 195 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 188 Pages
Global
From €3447EUR$3,939USD£2,997GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more